Halozyme

Performance

About Halozyme

Halozyme is a biotechnology company focused on disruptive drug delivery technologies and a robust commercial portfolio. It pioneers subcutaneous drug delivery with its ENHANZE platform, enabling partners to administer biologics more conveniently, potentially improving patient experience and treatment adherence. The company emphasizes reinvention of the patient experience through its delivery technologies and a broad product portfolio, supporting healthcare providers and patients globally.